Advertisement
Screener

Sio Gene Therapies Inc. Increase (Decrease) in Accrued Liabilities

Sio Gene Therapies Inc. Increase (Decrease) in Accrued Liabilities

Sio Gene Therapies Inc. reported Increase (Decrease) in Accrued Liabilities of -$6.28 million for the 9-month period ending 2022-12-31, per its 10-Q filed 2023-02-14.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2023-02-14

  • Sio Gene Therapies Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-12-31 was -$916.00K, a 331.31% decline year-over-year.
  • Sio Gene Therapies Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-09-30 was -$3.23M, a 431.01% decline year-over-year.
  • Sio Gene Therapies Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-06-30 was -$2.13M.
  • Sio Gene Therapies Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-03-31 was $470.00K, a 68.11% decline year-over-year.
  • Sio Gene Therapies Inc. increase (decrease) in accrued liabilities for fiscal 2022 was -$964.00K.
  • Sio Gene Therapies Inc. increase (decrease) in accrued liabilities for fiscal 2021 was -$2.12M.
  • Sio Gene Therapies Inc. increase (decrease) in accrued liabilities for fiscal 2020 was -$9.27M.
  • Sio Gene Therapies Inc. increase (decrease) in accrued liabilities for fiscal 2019 was -$11.24M.
Period endIncrease (Decrease) in Accrued Liabilities 2 monthIncrease (Decrease) in Accrued Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities 5 monthIncrease (Decrease) in Accrued Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities 9 monthIncrease (Decrease) in Accrued Liabilities 12 month
2022-12-31-$916.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-14
-$4.15M
derived: sum of 2 quarters · filed 2023-02-14
-$6.28M
10-Q · filed 2023-02-14
-$5.81M
derived: sum of 4 quarters · filed 2023-02-14
2022-09-30-$3.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-10
-$5.37M
10-Q · filed 2022-11-10
-$4.89M
derived: sum of 3 quarters · filed 2022-11-10
-$4.50M
derived: sum of 4 quarters · filed 2023-02-14
2022-06-30-$2.13M
10-Q · filed 2022-08-11
-$1.66M
derived: sum of 2 quarters · filed 2022-08-11
-$1.26M
derived: sum of 3 quarters · filed 2023-02-14
-$288.00K
derived: sum of 4 quarters · filed 2023-02-14
2022-03-31$470.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-14
$866.00K
derived: sum of 2 quarters · filed 2023-02-14
$1.84M
derived: sum of 3 quarters · filed 2023-02-14
-$964.00K
10-K · filed 2022-06-14
2021-12-31$396.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-14
$1.37M
derived: sum of 2 quarters · filed 2023-02-14
-$1.43M
10-Q · filed 2023-02-14
$40.00K
derived: sum of 4 quarters · filed 2023-02-14
2021-09-30$977.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-10
-$1.83M
10-Q · filed 2022-11-10
-$356.00K
derived: sum of 3 quarters · filed 2022-11-10
-$471.00K
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$2.81M
10-Q · filed 2022-08-11
-$1.33M
derived: sum of 2 quarters · filed 2022-08-11
-$1.45M
derived: sum of 3 quarters · filed 2022-08-11
-$2.56M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$1.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-14
$1.36M
derived: sum of 2 quarters · filed 2022-06-14
$247.00K
derived: sum of 3 quarters · filed 2022-06-14
-$2.12M
10-K · filed 2022-06-14
2020-12-31-$115.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-11
-$1.23M
derived: sum of 2 quarters · filed 2022-02-11
-$3.60M
10-Q · filed 2022-02-11
-$12.61M
derived: sum of 4 quarters · filed 2022-02-11
2020-09-30-$1.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-12
-$3.48M
10-Q · filed 2021-11-12
-$12.50M
derived: sum of 3 quarters · filed 2021-11-12
-$13.59M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30-$2.37M
10-Q · filed 2021-08-12
-$11.38M
derived: sum of 2 quarters · filed 2021-08-12
-$12.48M
derived: sum of 3 quarters · filed 2021-08-12
-$18.80M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31-$9.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-09
-$10.11M
derived: sum of 2 quarters · filed 2021-06-09
-$16.43M
derived: sum of 3 quarters · filed 2021-06-09
-$9.27M
10-K · filed 2021-06-09
2019-12-31-$1.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-09
-$7.41M
derived: sum of 2 quarters · filed 2021-02-09
-$251.00K
10-Q · filed 2021-02-09
-$2.54M
derived: sum of 4 quarters · filed 2021-02-09
2019-09-30-$6.32M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-13
$842.00K
10-Q · filed 2020-11-13
-$1.45M
derived: sum of 3 quarters · filed 2020-11-13
-$2.85M
derived: sum of 4 quarters · filed 2020-11-13
2019-06-30$7.16M
10-Q · filed 2020-08-11
$4.87M
derived: sum of 2 quarters · filed 2020-08-11
$3.46M
derived: sum of 3 quarters · filed 2020-08-11
$2.65M
derived: sum of 4 quarters · filed 2020-08-11
2019-03-31-$2.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-10
-$3.70M
derived: sum of 2 quarters · filed 2020-06-10
-$4.51M
derived: sum of 3 quarters · filed 2020-06-10
-$11.24M
10-K · filed 2020-06-10
2018-12-31-$1.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10
-$2.22M
derived: sum of 2 quarters · filed 2020-02-10
-$8.95M
10-Q · filed 2020-02-10
-$12.02M
derived: sum of 4 quarters · filed 2020-02-10
2018-09-30-$818.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-08
-$7.55M
10-Q · filed 2019-11-08
-$10.62M
derived: sum of 3 quarters · filed 2019-11-08
-$9.48M
derived: sum of 4 quarters · filed 2019-11-08
2018-06-30-$6.73M
10-Q · filed 2019-08-09
-$9.80M
derived: sum of 2 quarters · filed 2019-08-09
-$8.66M
derived: sum of 3 quarters · filed 2019-08-09
-$12.91M
derived: sum of 4 quarters · filed 2019-08-09
2018-03-31-$3.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-11
-$1.93M
derived: sum of 2 quarters · filed 2019-06-11
-$6.18M
derived: sum of 3 quarters · filed 2019-06-11
-$2.93M
10-K · filed 2019-06-11
2017-12-31$1.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-07
-$3.11M
derived: sum of 2 quarters · filed 2019-02-07
$139.00K
10-Q · filed 2019-02-07
$9.54M
derived: sum of 4 quarters · filed 2019-02-07
2017-09-30-$4.25M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-07
-$1.00M
10-Q · filed 2018-11-07
$8.40M
derived: sum of 3 quarters · filed 2018-11-07
$17.37M
derived: sum of 4 quarters · filed 2018-11-07
2017-06-30$3.25M
10-Q · filed 2018-08-07
$12.64M
derived: sum of 2 quarters · filed 2018-08-07
$21.61M
derived: sum of 3 quarters · filed 2018-08-07
$26.17M
derived: sum of 4 quarters · filed 2018-08-07
2017-03-31$9.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-11
$18.37M
derived: sum of 2 quarters · filed 2018-06-11
$22.92M
derived: sum of 3 quarters · filed 2018-06-11
$26.48M
10-K · filed 2018-06-11
2016-12-31$8.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-09
$13.53M
derived: sum of 2 quarters · filed 2018-02-09
$17.08M
10-Q · filed 2018-02-09
$20.00M
derived: sum of 4 quarters · filed 2018-06-11
2016-09-30$4.55M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-02
$8.11M
10-Q · filed 2017-11-02
$11.03M
derived: sum of 3 quarters · filed 2018-06-11
$14.49M
derived: sum of 4 quarters · filed 2018-06-11
2016-06-30$3.55M
10-Q · filed 2017-08-07
$6.47M
derived: sum of 2 quarters · filed 2018-06-11
$9.94M
derived: sum of 3 quarters · filed 2018-06-11
$10.63M
derived: sum of 4 quarters · filed 2018-06-11
2016-03-31$2.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-11
$6.38M
derived: sum of 2 quarters · filed 2018-06-11
$7.08M
derived: sum of 3 quarters · filed 2018-06-11
$8.39M
10-K · filed 2018-06-11
2015-12-31$3.46M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-14
$4.16M
derived: sum of 2 quarters · filed 2017-02-14
$5.47M
10-Q · filed 2017-02-14
2015-09-30$698.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-07
$2.01M
10-Q · filed 2016-11-07
2015-06-30$1.31M
10-Q · filed 2016-08-15
2015-03-31$468.00K
10-K · filed 2017-06-13
2014-12-31$6.00K
10-Q · filed 2016-02-09